Objective To analyze knowledge, perceptions, attitude, barriers and facilitators of biosimilars
uptake across physicians managing immune diseases and hospital pharmacists. Method
Two structured and closed anonymous online surveys were designed and sent to 41
physicians (rheumatologists, dermatologists, gastroenterologists) and 32 hospital
pharmacists. Sociodemographic and clinical practice related variables were collected. We
also gathered information about biosimilars knowledge and importance, access, attitude in …